Dyslipidemia

Dyslipidemia has long been recognised as a risk factor for atherosclerosis in T2DM patients. Diabetes is frequently associated with various patterns of dyslipidemia, which may increase atherogenic risk. Although patients with diabetes do not have significant increases in plasma LDL cholesterol levels, these levels are still predictive of cardiovascular risk. Diabetes causes LDL particles to be smaller and denser than normal LDL. These small, dense triglyceride-rich LDL particles are particularly dangerous. Small dense LDL particles are more prone to oxidation, especially in the presence of poor glucose control.

    Related Conference of Dyslipidemia

    October 20-21, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Dyslipidemia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in